Welcome to our dedicated page for Synopsys SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Synopsys funds relentless R&D, books multi-year license revenue, or discloses its latest IP acquisition can feel like decoding a 300-page textbook. That complexity is why questions such as 鈥淪ynopsys SEC filings explained simply鈥� or 鈥淪ynopsys insider trading Form 4 transactions鈥� appear so often in search boxes.
Stock Titan solves the puzzle. Our platform delivers AI-powered summaries that turn every Synopsys annual report 10-K simplified, each Synopsys quarterly earnings report 10-Q filing, and even the briefest Synopsys 8-K material events explained into clear narrative. Need real-time alerts? Synopsys Form 4 insider transactions real-time show exactly when executives exercise options, while the dashboard links directly to Synopsys executive stock transactions Form 4 for deeper context. You鈥檒l also find side-by-side Synopsys proxy statement executive compensation tables and concise Synopsys earnings report filing analysis, all updated the moment EDGAR releases.
The result: faster insight into how EDA tools, semiconductor IP, and software-security services shape revenue streams; instant visibility on share repurchases or option grants; and confidence when comparing backlog trends quarter-over-quarter. Whether you鈥檙e monitoring dilution risk, studying segment margins, or simply understanding Synopsys SEC documents with AI, every filing type鈥�10-K, 10-Q, 8-K, S-8, or Form 4鈥攊s ready when you are, explained in language that empowers decisive action.
Richard S. Mahoney, Chief Revenue Officer of Synopsys, Inc. (SNPS), reported an acquisition of company common stock under the Employee Stock Purchase Plan on 08/29/2025. The form shows he purchased 26 shares at a price of $376.771 per share. After the transaction his beneficial ownership is reported as 1,511 shares, held directly. The filing was submitted via power of attorney by Liz Ramirez on 09/03/2025. No derivative transactions or additional changes are disclosed.
Synopsys Inc. (SNPS) filed a Form 144 notifying a proposed sale of 11,366 common shares via Morgan Stanley Smith Barney LLC on 09/02/2025. The filing shows an aggregate market value of $6,694,724.03 and total shares outstanding of 155,160,938. The shares were acquired the same day through a stock option exercise from the issuer, with payment made in cash. No securities sales by the reporting person were reported in the prior three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Synopsys (SNPS) 鈥� Form 4 insider update
On 31 Jul 2025 Director Ajei Gopal converted 117,256 restricted stock units into common shares at a $0 exercise price. To cover tax obligations, 46,153 shares were automatically withheld and sold back to the company at $633.47, a transaction valued at roughly $29.3 million. Net of withholding, his direct ownership rose by 71,103 shares, taking his total stake to 166,606 shares.
Per the separation agreement cited in the filing, all of Gopal鈥檚 remaining unvested RSUs were accelerated and vested in connection with his termination of employment. The dispositions were strictly for tax-withholding purposes; no open-market sales were reported.
FAQ
What is the current stock price of Synopsys (SNPS)?
What is the market cap of Synopsys (SNPS)?
